Structure Therapeutics Inc ADR (NASDAQ: GPCR) stock jumped 12.14% on Friday to $53.77 against a previous-day closing price of $47.95. With 1.06 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.91 million shares. The 52-week range on GPCR shows that it touched its highest point at $75.02 and its lowest point at $20.80 during that stretch. It currently has a 1-year price target of $89.17.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of GPCR was down-trending over the past week, with a drop of -2.00%, but this was down by -19.70% over a month. Three-month performance surged to 85.35% while six-month performance rose 121.82%. A look at the trailing 12-month EPS for GPCR yields -2.30 with Next year EPS estimates of -0.99. For the next quarter, that number is -0.21. This implies an EPS growth rate of 83.56% for this year and -14.74% for next year.
Float and Shares Shorts:
At present, 36.59 million GPCR shares are outstanding with a float of 32.69 million shares on hand for trading. On Oct 30, 2023, short shares totaled 2.74 million, which was 6.20% higher than short shares on Sep 28, 2023. In addition to Dr. Raymond C. Stevens Ph.D. as the firm’s CEO & Director, Dr. Yingli Ma Ph.D. serves as its Chief Technology Officer.
Through their ownership of 41.29% of GPCR’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 50.95% of GPCR, in contrast to 18.84% held by mutual funds. As the largest shareholder in GPCR with 6.01% of the stake, T. Rowe Price Associates, Inc. holds 2,513,563 shares worth 2,513,563. A second-largest stockholder of GPCR, Driehaus Capital Management LLC, holds 2,388,876 shares, controlling over 5.72% of the firm’s shares. Janus Henderson Investors US LLC is the third largest shareholder in GPCR, holding 1,943,918 shares or 4.65% stake. With a 1.70% stake in GPCR, the T Rowe Price New Horizons Fund is the largest stakeholder. A total of 709,313 shares are owned by the mutual fund manager. The Federated Hermes Kaufmann Small C, which owns about 1.41% of GPCR stock, is the second-largest Mutual Fund holder. It holds 587,500 shares valued at 43.65 million. Federated Hermes Kaufmann Fund holds 1.20% of the stake in GPCR, owning 500,000 shares worth 37.15 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for GPCR since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With GPCR analysts setting a high price target of $97.00 and a low target of $79.00, the average target price over the next 12 months is $89.17. Based on these targets, GPCR could surge 80.4% to reach the target high and rise by 46.92% to reach the target low. Reaching the average price target will result in a growth of 65.84% from current levels.